Abstract
Rosacea is characterized by a wide variety of vascular changes. Apart from telangiectasia and erythema, often so-called flushing occurs. These vascular abnormalities can be targeted with specific light and laser devices. In addition to KTP laser, dye laser (FDL), and Nd:YAG laser, also intense pulsed light devices (IPLs) are used. The described therapeutic effects include reduction in vascular abnormalities and even improvement in papulopustular changes. While the KTP laser shows very good results in telangiectasia, the dye laser and IPL devices are used preferably in erythema. The Nd:YAG laser is also a possibility for patients with telangiectasia and erythema. However, compared to other laser and light devices the Nd:YAG laser carries the highest risk of unpredictable scarring.
Phymatous changes are another clinical manifestation of rosacea, mostly affecting the nose (rhinophyma). Moderate and severe cases are commonly treated with ablation modalities. Traditional surgery is a treatment option, but is often associated with major intraoperative bleeding. Alternative methods include electrosurgery and dermabrasion, though both methods can cause scarring. Newer methods such as CO2 laser ablation, possibly in combination with the erbium:YAG laser, are safe alternatives with a lower risk of complications. In a very recent study the application of the 577-nm Pro Yellow laser has also shown good results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Schaller M, Schöfer H, Homey B, et al. Rosacea management: update on general measures and topical treatment options. J Dtsch Dermatol Ges. 2016;14:17–28.
Schaller M, Schöfer H, Homey B, et al. State of the art: systemic rosacea management. J Dtsch Dermatol Ges. 2016;14:29–37.
Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69:S15–26.
Holmes AS, Steinhoff M. Integrative concepts of rosacea pathophysiology, presentation, and therapeutics. Exp Dermatol. 2017;26(8):659–67.
Arndt KA. Argon laser therapy of small cutaneous vascular lesions. Arch Dermatol. 1982;118:220–4.
Laube S, Lanigan SW. Laser treatment of rosacea. J Cosmet Dermatol. 2002;1:188–95.
van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev. 2015;4:CD003262.
Clark SM, Lanigan SW, Marks R. Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci. 2002;17:26–33.
Jasim ZF, Woo WK, Handley JM. Long-pulsed (6-ms) pulsed dye laser treatment of rosacea-associated telangiectasia using subpurpuric clinical threshold. Dermatol Surg. 2004;30:37–40.
Bernstein EF, Kligman A. Rosacea treatment using the new-generation, high-energy, 595 nm, long pulse-duration pulsed-dye laser. Lasers Surg Med. 2008;40:233–9.
Gallo R, Drago F, Paolino S, Parodi A. Rosacea treatments: what’s new and what’s on the horizon? Am J Clin Dermatol. 2010;11:299–303.
Tan ST, Bialostocki A, Armstrong JR. Pulsed dye laser therapy for rosacea. Br J Plast Surg. 2004;57:303–10.
Tan SR, Tope WD. Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol. 2004;51:592–9.
Lonne-Rahm S, Nordlind K, Edstrom DW, Ros AM, Berg M. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol. 2004;140:1345–9.
Salem SA, Abdel Fattah NS, Tantawy SM, El-Badawy NM, Abd El-Aziz YA. Neodymium-yttrium aluminum garnet laser versus pulsed dye laser in erythemato-telangiectatic rosacea: comparison of clinical efficacy and effect on cutaneous substance (p) expression. J Cosmet Dermatol. 2013;12:187–94.
Kim SJ, Lee Y, Seo YJ, Lee JH, Im M. Comparative efficacy of radiofrequency and pulsed dye laser in the treatment of rosacea. Dermatol Surg. 2017;43:204–9.
West TB, Alster TS. Comparison of the long-pulse dye (590-595 nm) and ktp (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24:221–6.
Uebelhoer NS, Bogle MA, Stewart B, Arndt KA, Dover JS. A split-face comparison study of pulsed 532-nm ktp laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol Surg. 2007;33:441–8.
Say EM, Okan G, Gokdemir G. Treatment outcomes of long-pulsed Nd: Yag laser for two different subtypes of rosacea. J Clin Aesthet Dermatol. 2015;8:16–20.
Willey A, Anderson RR, Azpiazu JL, Bakus AD, Barlow RJ, Dover JS, Garden JM, Kilmer SL, Landa N, Manstein D, Ross EV Jr, Sadick N, Tanghetti EA, Yaghmai D, Zelickson BD. Complications of laser dermatologic surgery. Lasers Surg Med. 2006;38:1–15.
Karsai S, Roos S, Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34:702–8.
Alam M, Voravutinon N, Warycha M, Whiting D, Nodzenski M, Yoo S, West DP, Veledar E, Poon E. Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:Yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: a double-blind randomized controlled trial. J Am Acad Dermatol. 2013;69:438–43.
Baek JO, Hur H, Ryu HR, Kim JS, Lee KR, Kim YR, Choi KH. Treatment of erythematotelangiectatic rosacea with the fractionation of high-fluence, long-pulsed 595-nm pulsed dye laser. J Cosmet Dermatol. 2017;16:12–4.
Strand M, Bergqvist G, Griffith S, Bergqvist E. The effect of recurrent pulsed dye laser treatments in rosacea patients. J Cosmet Laser Ther. 2017;19:160–4.
Ko HS, Suh YJ, Byun JW, Choi GS, Shin J. Pulsed dye laser treatment comined with oral minocycline reduces recurrence rate of rosacea. Ann Dermatol. 2017;29:543–7.
Bernstein EF, Schomacker K, Paranjape A, Jones CJ. Pulsed dye laser treatment of rosacea using a novel 15 mm diameter treatment beam. Lasers Surg Med. 2018;50:808–12.
Taub AF. Treatment of rosacea with intense pulsed light. J Drugs Dermatol. 2003;2:254–9.
Kassir R, Kolluru A, Kassir M. Intense pulsed light for the treatment of rosacea and telangiectasias. J Cosmet Laser Ther. 2011;13:216–22.
Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M. Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol. 2008;159:628–32.
Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea. Dermatol Surg. 2009;35:920–8.
Nymann P, Hedelund L, Haedersdal M. Long-pulsed dye laser vs. Intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24:143–6.
Tsunoda K, Akasaka K, Akasaka T, Amano H. Successful treatment of erythematotelangiectatic rosacea with intense pulsed light: report of 13 cases. J Dermatol. 2018;45:1113–6.
Sadick H, Riedel F, Bran G. Rhinophyma in rosacea. What does surgery achieve? Hautarzt. 2011;62:834–41.
Hoasjoe DK, Stucker FJ. Rhinophyma: review of pathophysiology and treatment. J Otolaryngol. 1995;24:51–6.
Farina R, Piza Pde T. Blepharoptosis; blepharoplasty by a modified wiener-lexer technique. Plast Reconstr Surg (1946) 1950;5:97–101, illust.
González LF, Herrera H, Motta A. Electrosurgery for the treatment of moderate or severe rhinophyma. Actas Dermosifiliogr. 2018;109:e23–6.
Krausz AE, Goldberg DJ, Ciocon DH, Tinklepaugh AJ. Procedural management of rhinophyma: a comprehensive review. J Cosmet Dermatol. 2018;17:960–7.
Moreira A, Leite I, Guedes R, Baptista A, Mota G. Surgical treatment of rhinophyma using carbon dioxide (co2) laser and pulsed dye laser (pdl). J Cosmet Laser Ther. 2010;12:73–6.
Goon PK, Dalal M, Peart FC. The gold standard for decortication of rhinophyma: combined erbium-yag/co2 laser. Aesthet Plast Surg. 2004;28:456–60.
Menezes N, Moreira A, Mota G, Baptista A. Quality of life and rosacea: pulsed dye laser impact. J Cosmet Laser Ther. 2009;11:139–41.
Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014;71:973–80.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hofmann, M.A., Lehmann, P. (2020). Physical Modalities for the Treatment of Rosacea. In: Cary, J.H., Maibach, H.I. (eds) Rosacea. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-52097-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-52097-7_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-52096-0
Online ISBN: 978-3-030-52097-7
eBook Packages: MedicineMedicine (R0)